fusion-antibodies
Founded 2001 · 30 employees on LinkedIn · 1 known investors
Fusion Antibodies is a contract research provider offering end-to-end antibody development services, from antigen design through cell line development, for organizations advancing therapeutic antibodies toward the clinic. It works as an extension of client teams with attention to manufacturability and commercialization.
Investors · 1
Frequently asked questions
- What does fusion-antibodies do?
- Fusion Antibodies is a contract research provider offering end-to-end antibody development services, from antigen design through cell line development, for organizations advancing therapeutic antibodies toward the clinic. It works as an extension of client teams with attention to manufacturability and commercialization.
- Who are fusion-antibodies's investors?
- fusion-antibodies's investors include Clarendon Fund Managers Ltd..